Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Diabetologist
MBBS, FCPS, MCPS, Fellowship in Diabetes and Endocrinology, MPH
Diabetologist
MBBS, FCPS, MCPS, Fellowship in Diabetes and Endocrinology, MPH
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Internal Medicine Specialist
M.B.B.S, M.R.C.P (UK), M.D (US)
Diabetologist
MBBS, MPH, Certification Course in Diabetology (UK), Diploma in Diabetology & Endocrinology
Diabetologist
MBBS, MPH, Certification Course in Diabetology (UK), Diploma in Diabetology & Endocrinology
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures